Molina Healthcare shares slide as investors refocus on cost and membership headwinds

Molina Healthcare, Inc. (MOH) is down 4.3% today. Here is some analysis on what might have caused this price movement.

Analysis: No single company-specific headline clearly explains today’s drop, so the move looks most consistent with a sentiment-driven pullback. Investors may be re-pricing near-term risk tied to elevated medical costs and Medicaid membership pressure highlighted in recent company disclosures. This could also be simple profit-taking after a prior run-up, with the stock remaining sensitive to government-program policy and rate-setting headlines.

Details:

The company’s April 22, 2026 update showed first-quarter 2026 medical care ratio rising to 91.1% from 89.2% a year earlier, keeping investor focus on utilization and cost trend risk.

Molina reported serving about 5.0 million members as of March 31, 2026, and cited lower Medicaid membership (including Virginia contract expiration) plus lower Marketplace membership as drivers of year-over-year premium revenue decline.

The company reaffirmed full-year 2026 guidance for approximately $42 billion of premium revenue and at least $5.00 in adjusted EPS, which may still be viewed as vulnerable if utilization surprises persist through midyear.

A recent credit-rating action added another overhang for risk-sensitive investors, especially if operating performance remains volatile.

Sources:

Molina Healthcare Investor Relations, S&P Global Ratings, Centers for Medicare & Medicaid Services

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$MOH Insider Trading Activity

$MOH insiders have traded $MOH stock on the open market 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $MOH stock by insiders over the last 6 months:

JEFF D. BARLOW (Chief Legal Officer) sold 17,811 shares for an estimated $3,314,983
MAURICE HEBERT (Chief Accounting Officer) sold 600 shares for an estimated $114,930
RICHARD C ZORETIC purchased 800 shares for an estimated $100,128
RONNA ROMNEY sold 506 shares for an estimated $74,341

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive MOH Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$MOH Hedge Fund Activity

We have seen 315 institutional investors add shares of $MOH stock to their portfolio, and 440 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

BLACKROCK, INC. added 2,476,708 shares (+63.6%) to their portfolio in Q1 2026, for an estimated $331,197,777
AQR CAPITAL MANAGEMENT LLC added 2,452,990 shares (+597.7%) to their portfolio in Q1 2026, for an estimated $328,026,087
HARRIS ASSOCIATES L P removed 1,368,290 shares (-58.3%) from their portfolio in Q1 2026, for an estimated $182,974,580
8 KNOTS MANAGEMENT, LLC added 1,146,378 shares (+inf%) to their portfolio in Q4 2025, for an estimated $198,942,438
JANE STREET GROUP, LLC added 712,027 shares (+591.0%) to their portfolio in Q1 2026, for an estimated $95,215,810
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 679,223 shares (-34.5%) from their portfolio in Q4 2025, for an estimated $117,872,359
MAVERICK CAPITAL LTD added 645,768 shares (+inf%) to their portfolio in Q1 2026, for an estimated $86,355,325

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$MOH Analyst Ratings

Wall Street analysts have issued reports on $MOH in the last several months. We have seen 1 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

Wells Fargo issued a "Overweight" rating on 01/07/2026
Barclays issued a "Underweight" rating on 01/05/2026

To track analyst ratings and price targets for $MOH, check out Quiver Quantitative's $MOH forecast page.

$MOH Price Targets

Multiple analysts have issued price targets for $MOH recently. We have seen 10 analysts offer price targets for $MOH in the last 6 months, with a median target of $171.5.

Here are some recent targets:

Andrew Mok from Barclays set a target price of $199.0 on 05/26/2026
A.J. Rice from UBS set a target price of $202.0 on 05/22/2026
Michael Ha from Baird set a target price of $163.0 on 05/11/2026
Sarah James from Cantor Fitzgerald set a target price of $209.0 on 05/11/2026
David Macdonald from Truist Securities set a target price of $205.0 on 05/11/2026
Stephen Baxter from Wells Fargo set a target price of $159.0 on 04/27/2026
Erin Wright from Morgan Stanley set a target price of $146.0 on 04/24/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.